Page 2 - Dr Reddy's Laboratories Limited
Nifty outlook & trading ideas by HDFC Sec: Buy Bajaj Finance, Dr Reddy's
Bajaj Finance's stock price has broken out from symmetrical triangle on the daily charts, and rising volumes have confirmed the breakout
Dr Reddy's bullish on OTC products sale through Amazon, others in US
Dr Reddy's first began selling its OTC Habitrol brand nicotine patches on Amazon in 2016, as an experiment.
Sensex, Nifty post fourth straight weekly rise; Dr Reddy's rises over 3%
After rising 341 points, the Sensex settled 174 points, or 0.33 per cent, higher at 52,475
Hyderabad's Rockwell collaborates with Dr Reddy's Lab for Sputnik V rollout
Rockwell Industries has got orders for 750 Covid19 vaccine freezers from hospitals and institutions.
Dr Reddy's lines up Rs 1,000 cr capex for current fiscal on growth outlook
Dr Reddy's Laboratories has earmarked a Capex of around Rs 1,000 crore for the current fiscal as it remains positive about sustaining its growth trends in the current fiscal, top company official said
Shilpa Medicare jumps 26% in 2 days on tie-up with DRL for Covid vaccine
The company has entered into a three-year Definitive Agreement with Dr. Reddy's for production-supply of the Sputnik V vaccine
Russia's Sputnik V vaccine for Covid priced at Rs 948 plus 5% GST in India
Inoculation could be cheaper when it is manufactured domestically, says Hyderabad company.
Expert panel recommends approval to Russia's Sputnik V Covid-19 vaccine
Now, the Drugs Controller General of India DCGI will consider this recommendation and decide whether to grant Sputnik V approval for restricted emergency use in India
Pharma shares in demand; Cipla, Laurus Labs, Dr Lal Pathlabs hit new highs
Analysts at Phillip Capital believe that it is not over for the Indian pharma - and that it is all set for a sectoral value upgrade
Dr Reddy's Labs terminates Kuwait-based Covid-19 treatment study
Dr Reddy's Laboratories on Wednesday announced termination of Avigan trial study being conducted in Kuwait
Sensex up 248 pts at 49,517; Nifty at 14,563; SBI, Airtel soar 4%, RIL 3%
Stock market updates: Nifty PSU Bank index surged over 6 per cent and was the top sectoral gainer
PM holds virtual meet with teams developing, manufacturing Covid-19 vaccine
The teams were from Gennova Biopharmaceuticals Ltd in Pune, Biological E Ltd and Dr Reddys Laboratories Ltd in Hyderabad.
Dr Reddy's gets nod for 2/3 vaccine trial; Key updates about the virus
A PMO release said three vaccines are in advanced stages of development in India, out of which two are in Phase II and one is in Phase-III
Strong support exists for Nifty at 10,900: CapitalVia Global Research
A short-covering move, along with addition of fresh position, is seen only if somehow Nifty sustains level of 11,200
Dr Reddy's, Biocon, Torrent Pharma: What charts indicate for these stocks
The next upside for Nifty Pharma is located above the resistance of 12,100 levels.
Dr Reddy's Labs gains for second straight day on Covid vaccine deal
Upon regulatory approval in India, RDIF shall supply to Dr. Reddy's 100 million doses of the vaccine
New launches, patents: Multiple catalysts for Dr Reddy's US business
The ongoing pace of product launches in the US should lead to stronger growth after a good Q1, say analysts
Dr Reddy's launches cancer drug Abiraterone Acetate in US market
The drug is a therapeutic equivalent generic version of Zytiga owned by Johnson & Johnson
Dr Reddy's closes Wockhardt branded generics deal on modified terms
Under new terms, DRL to hold back Rs 300 crore and release it if the revenue from sale of the products forming part of the business undertaking during the 12 months post-closing exceeds Rs 480 cr
Centre keen on testing Gilead's remdesivir to combat coronavirus
The USFDA has recently given an emergency approval to the drug for use on coronavirus patients
